RELATED CONTENT
NEWS
- European generics firms, squeezed between innovators and payers, seek diversity
- Express Scripts $29.1 billion bid for Medco will hit US FTC scrutiny and squeeze pharma
- Eisai's Halaven stumbles at NICE efficacy hurdle
- UK govt offers "step change" in support for regenerative medicine

